ANGO on Nasdaq
ANGIODYNAMICS INC
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with TACTILE SYSTEMS TECHNOLOGY INC, PROCEPT BioRobotics Corp or SkinHealth Systems Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
54.6%Gross margin2
-12.5%Operating margin2
-11.5%Net margin3
9.5%Revenue growth, 20262
-21.5%Return on equity2
$508.0KFree cash flow2
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Med Device brought in 53% of the revenue ANGIODYNAMICS INC broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Med Device | $197.5M | $165.8M | $170.2M |
| Med Tech | $106.4M | $126.7M | $150.0M |
Business segments
Med Device brought in 53% of the revenue ANGIODYNAMICS INC broke down this way in fiscal 2026.
Business segments by year
| Business segments | 2024 | 2025 | 2026 |
|---|---|---|---|
| Med Device | $197.5M | $165.8M | $170.2M |
| Med Tech | $106.4M | $126.7M | $150.0M |
Regions
United States brought in 86% of the revenue ANGIODYNAMICS INC broke down this way in fiscal 2026.
Regions by year
| Regions | 2024 | 2025 | 2026 |
|---|---|---|---|
| United States | $251.5M | $251.0M | $274.9M |
| Outside the United States | $52.4M | $41.5M | $45.3M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue45¢$145.3M
- Research and development9¢$29.4M
- Other costs45¢$145.0M
- Income tax0¢$442.0K
Out of $320.2M in revenue.23 The company lost money this year.
Where each dollar of operating cash went, fiscal 2026
- Capital spending84¢$2.6M
- Kept or used elsewhere16¢$508.0K
Out of $3.1M of cash from operations.2
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 |
|---|---|---|---|
| Net sales | $320.2M | $292.5M | $303.9M |
| Cost of sales (exclusive of intangible amortization) | $145.3M | $134.8M | $149.2M |
| Gross margin | $174.9M | $157.7M | $154.7M |
| Research and development | $29.4M | $26.2M | $31.5M |
| Sales and marketing | $113.4M | $103.1M | $102.8M |
| General and administrative | $43.7M | $42.1M | $41.2M |
| Amortization of intangibles | $10.7M | $10.3M | $13.0M |
| Goodwill impairment | $0 | $0 | $159.5M |
| Change in fair value of contingent consideration | $0 | $272.0K | $432.0K |
| Acquisition, restructuring and other items, net | $17.6M | $15.6M | $53.2M |
| Total operating expenses | $214.8M | $197.7M | $401.6M |
| Gain on sale of assets | $0 | $0 | $54.5M |
| Operating loss | -$39.9M | -$40.0M | -$192.4M |
| Interest income (expense), net | -$299.0K | $978.0K | $1.6M |
| Other income (expense), net | $3.9M | $4.9M | -$817.0K |
| Total other income, net | $3.6M | $5.9M | $797.0K |
| Loss before income tax expense (benefit) | -$36.3M | -$34.0M | -$191.6M |
| Income tax expense (benefit) | $442.0K | -$39.0K | -$7.3M |
| Net loss | -$36.7M | -$34.0M | -$184.3M |
| Basic (usd per share) | -$0.88 | -$0.83 | -$4.59 |
| Diluted (usd per share) | -$0.88 | -$0.83 | -$4.59 |
| Basic (in shares) | 41.5M shares | 40.9M shares | 40.2M shares |
| Diluted (in shares) | 41.5M shares | 40.9M shares | 40.2M shares |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 |
|---|---|---|---|
| Cash and cash equivalents | $53.9M | $55.9M | |
| Accounts receivable, net of allowances of $1,851 and $2,215 respectively | $48.3M | $42.9M | |
| Inventories | $52.4M | $62.0M | |
| Prepaid expenses and other | $8.8M | $7.5M | |
| Total current assets | $163.4M | $168.3M | |
| Property, plant and equipment, Net | $27.1M | $32.3M | |
| Intangible assets, net | $67.2M | $69.1M | |
| Other assets | $9.5M | $10.4M | |
| Total Assets | $267.2M | $280.1M | |
| Accounts payable | $31.5M | $33.3M | |
| Accrued liabilities | $38.9M | $35.5M | |
| Other current liabilities | $4.3M | $7.4M | |
| Total current liabilities | $74.7M | $76.2M | |
| Deferred income taxes | $5.3M | $4.1M | |
| Other long-term liabilities | $16.3M | $16.9M | |
| Total Liabilities | $96.3M | $97.2M | |
| Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding | $0 | $0 | |
| Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,314,266 and 41,607,877 shares issued and 41,700,419 and 40,994,030 shares outstanding at May 31, 2026 and 2025, respectively | $387.0K | $385.0K | |
| Additional paid-in capital | $636.1M | $621.2M | |
| Accumulated deficit | -$465.9M | -$429.2M | |
| Treasury stock, 613,847 shares, at cost at May 31, 2026 and 2025, respectively | -$7.4M | -$7.4M | |
| Accumulated other comprehensive loss | $7.7M | -$2.0M | |
| Total Stockholders' Equity | $170.8M | $183.0M | $205.6M |
| Total Liabilities and Stockholders' Equity | $267.2M | $280.1M | |
| Treasury stock, shares (shares) | 613.8K shares | 613.8K shares | |
| Accounts receivable, allowances | $1.9M | $2.2M | |
| Preferred stock, par value (usd per share) | $0.01 | $0.01 | |
| Preferred stock, shares authorized (shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, shares issued (shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (shares) | 0 shares | 0 shares | |
| Common stock, par value (usd per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (shares) | 75.0M shares | 75.0M shares | |
| Common stock, shares issued (shares) | 42.3M shares | 41.6M shares | |
| Common stock, shares outstanding (shares) | 41.7M shares | 41.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 |
|---|---|---|---|
| Net loss | -$36.7M | -$34.0M | -$184.3M |
| Depreciation and amortization | $23.0M | $25.8M | $27.7M |
| Non-cash lease expense | $1.6M | $2.0M | $1.9M |
| Non-cash interest expense | $290.0K | $0 | $0 |
| Goodwill impairment | $0 | $0 | $159.5M |
| Stock based compensation | $14.0M | $9.8M | $10.5M |
| Gain on dispositions | $0 | $0 | -$54.5M |
| Transaction costs for disposition | $0 | $0 | -$5.1M |
| Change in fair value of contingent consideration | $0 | $272.0K | $432.0K |
| Deferred income tax provision | $143.0K | -$988.0K | -$8.0M |
| Changes in accounts receivable allowances | $313.0K | $699.0K | $1.3M |
| Asset impairments and disposals | $1.3M | $173.0K | $7.1M |
| Write-off of other assets | $0 | $0 | $869.0K |
| Other | $2.0M | $291.0K | -$62.0K |
| Accounts receivable | -$5.8M | $23.0K | $7.9M |
| Inventories | $10.0M | -$1.3M | -$9.4M |
| Prepaid expenses and other | -$1.1M | $3.1M | -$11.6M |
| Accounts payable, accrued and other liabilities | -$5.8M | -$15.9M | $27.5M |
| Net cash provided by (used in) operating activities | $3.1M | -$10.1M | -$28.2M |
| Additions to property, plant and equipment | -$2.6M | -$4.5M | -$2.5M |
| Additions to placement and evaluation units | -$3.4M | -$5.7M | -$5.0M |
| Proceeds from sale of assets | $0 | $0 | $134.5M |
| Acquisition of intangibles | $0 | $0 | -$3.2M |
| Net cash (used in) provided by investing activities | -$5.9M | -$10.2M | $123.7M |
| Repayment of long-term debt | $0 | $0 | -$50.0M |
| Deferred financing costs on long-term debt | $0 | -$680.0K | $0 |
| Principal payments on financing arrangement | -$375.0K | -$148.0K | $0 |
| Proceeds from financing arrangement | $0 | $6.3M | $0 |
| Payment of acquisition related contingent consideration | $0 | -$5.0M | -$15.0M |
| Repurchase of common stock | $0 | -$1.7M | $0 |
| Proceeds from exercise of stock options and employee stock purchase plan | $939.0K | $933.0K | $752.0K |
| Net cash provided by (used in) financing activities | $564.0K | -$255.0K | -$64.2M |
| Effect of exchange rate changes on cash and cash equivalents | $267.0K | $398.0K | $125.0K |
| Increase (decrease) in cash and cash equivalents | -$2.0M | -$20.2M | $31.4M |
| Increase (decrease) in accounts payable for purchases of fixed assets | -$68.0K | -$49.0K | -$78.0K |
| Interest | $426.0K | $185.0K | $0 |
| Income taxes | $405.0K | $800.0K | $455.0K |
Recent filings
- Oct 8, 20268-K
- Oct 8, 20268-K
- Oct 8, 2026DEF 14A
- Oct 8, 2026DEFA14A
- Oct 8, 202610-Q
- Sep 29, 202610-K/A
- Sep 29, 202610-K/A
- Jul 31, 20264
- Jul 30, 2026144
- Jul 24, 20264
- Jul 24, 20264
- Jul 24, 20264
- Jul 24, 20264
- Jul 24, 20264
- Jul 22, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14